Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2000 Feb;91(2):261–269. doi: 10.1111/j.1349-7006.2000.tb00940.x

Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride

Katsuyoshi Hori 1,✉, Sachiko Saito 1, Hiroto Takahashi 2, Haruhiko Sato 3, Hiroshi Maeda 4, Yasufumi Sato 1
PMCID: PMC5926331  PMID: 10761715

Abstract

To enhance chemotherapeutic efficacy against cancer, it is important to deliver anticancer drugs preferentially to cancer cells and to retain the drugs there for a prolonged time. The in vivo prolongation of the exposure time of anticancer drugs in tumors can be accomplished by decreasing tumor tissue blood flow (tBF) after anticancer drug administration. The present study demonstrated that temocapril hydrochloride, an angiotensin converting enzyme inhibitor, decreases tumor tBF markedly in LY80 tumor, a subline of Yoshida sarcoma in the rat, without affecting the blood flow in liver, kidney, bone marrow, and brain. In tumor areas with flow of above 20 ml/min/ 100 g, the tBF decreased by approximately 50% due to temocapril. In tumor areas with tBF of about 20 ml/min/100 g, it became less than 3 ml/min/100 g with temocapril and did not recover during the 2 h experiment. These findings were obtained not only in large tumors, but also in microfoci growing within a transparent chamber. Furthermore, even when temocapril was administered under the condition of increased tumor tBF by administering angiotensin II, tumor tBF decreased immediately. Using this technique, it should be possible to trap anticancer drugs selectively in tumor tissue for an extended period of time.

Keywords: Tumor blood flow, Drug delivey system, Temocapril hydrochloride, Angiotensin II, ACE inhibitor

Full Text

The Full Text of this article is available as a PDF (7.3 MB).

REFERENCES

  • 1. ) Suzuki , M. , Hori , K. , Abe , I. , Saito , S. and Sato , H.Functional characterization of the microcirculation in tumors . Cancer Metastasis Rev. , 3 , 115 – 126 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Chaplin , D. J. , Horsman , M. R. , Trotter , M. J. and Siemann , D. W.Therapeutic significance of microenvironmental factors . In“Blood Perfusion and Microenvironment of Human Tumors: Implications for Clinical Radiooncology ,” ed. Vaupel P. and Molls M. , pp. 133 – 143 ( 1998. ). Springer; , Berlin . [Google Scholar]
  • 3. ) Song , C. W.Modification of blood flow . In“Blood Perfusion and Microenvironment of Human Tumors: Implications for Clinical Radiooncology ,” ed. Vaupel P. and Molls M. , pp. 193 – 207 ( 1998. ). Springer; , Berlin . [Google Scholar]
  • 4. ) Suzuki , M.Selective increase in intratumoral concentration of anticancer drugs and extension of retention time based on two functional characteristics of tumor vessels . Adv. Cancer Treat. , 7 , 77 – 81 ( 1988. ).( in Japanese ). [Google Scholar]
  • 5. ) Pruijn , F. B. , van Daalen , M. , Holford , N. H. G. and Wilson , W. R.Mechanisms of enhancement of the antitumour activity of melphalan by the tumour‐blood‐flow inhibitor 5,6‐dimethylxanthenone‐4‐acetic acid . Cancer Chemother. Pharmacol. , 39 , 541 – 546 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Suzuki , M. , Hori , K. , Abe , I. , Saito , S. and Sato , H.A new approach to cancer chemotherapy. Selective enhancement of tumor blood flow with angiotensin II . J. Natl. Cancer Inst. , 67 , 663 – 669 ( 1981. ). [PubMed] [Google Scholar]
  • 7. ) Abe , I. , Hori , K. , Saito , S. , Tanda , S. , Li , Y. and Suzuki , M.Increased intratumor concentration of fluorescein‐isothiocyanate‐labeled neocarzinostatin in rats under angiotensininduced hypertension . Jpn. J. Cancer Res. ( Gann ), 79 , 874 – 879 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. ) Sato , H. , Sugiyama , K. , Hoshi , M. , Urushiyama , M. and Ishizuka , K.Angiotensin II (AII) induced hypertension chemotherapy (IHC) for unresectable gastric cancer: with reference to resection after down staging . World J. Surg. , 19 , 836 – 842 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Algire , G. H. , Legallais , F. Y. and Anderson , B. F.Vascular reaction of normal and malignant tissue in vivo. VI. The role of hypotension in the action of components of podophyllin on transplantable sarcomas . J. Natl. Cancer Inst. , 14 , 879 – 893 ( 1954. ). [PubMed] [Google Scholar]
  • 10. ) Cater , D. B. , Grigson , C. M. B. and Watkinson , D. A.Changes of oxygen tension in tumours induced by vasoconstrictor and vasodilator drugs . Acta Radiol. , 58 , 401 – 434 ( 1962. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Peters , C. E. and Chaplin , D. J.Blood flow modification in the SCCVII tumor: effects of 5‐hydroxytryptamine, hydralazine, and propranolol . Int. J. Radiat. Oncol. Biol. Phys. , 22 , 463 – 465 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Chaplin , D. J. and Acker , B.The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU‐ 1069: evidence for therapeutic gain . Int. J. Radiat. Oncol. Biol. Phys. , 13 , 579 – 585 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Krossnes , B. K. , Mella , O. and Tyssebotn , I.Effect of sodium nitroprusside‐induced hypotension on the blood flow in subcutaneous and intramuscular BT4AN tumors and normal tissues in rats . Int. J. Radiat. Oncol. Biol. Phys. , 36 , 393 – 401 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Hill , S. , Williams , K. B. and Denekamp , J.Vascular collapse after flavone acetic acid: a possible mechanism of its anti‐tumor action . Eur. J. Cancer Clin. Oncol. , 25 , 1419 – 1424 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Bibby , M. C. , Double , J. A. , Loadman , P. M. and Duke , C. V.Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy . J. Natl. Cancer Inst. , 81 , 216 – 220 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Zwi , L. J. , Baguley , B. C. , Gavin , J. B. and Wilson , W. R.Blood flow failure as a major determinant in the antitumor action of flavone acetic acid . J. Natl. Cancer Inst. , 81 , 1005 – 1013 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Kallinowski , F. , Shaefer , C. , Tyler , G. and Vaupel , P.In vivo targets of recombinant human tumour necrosis factor —blood flow, oxygen consumption and growth of isotransplanted rat tumours . Br. J. Cancer , 60 , 555 – 560 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Baguley , B. C. , Holdaway , K. M. , Thomsen , L. L. , Zhuang , L. and Zwi , L. J.Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism . Eur. J. Cancer , 27 , 482 – 487 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Hill , S. A. , Lonergan , S. J. , Denekamp , J. and Chaplin , D. J.Vinca alkaloids: anti‐vascular effects in a murine tumor . Eur. J. Cancer , 29A , 1320 – 1324 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Cliffe , S. , Taylor , M. L. , Rutland , M. , Baguley , B. C. , Hill , R. P. and Wilson , W. R.Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6‐dimethylxanthenone acetic acid . Int. J. Radiat. Oncol. Biol. Phys. , 29 , 373 – 377 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Tozer , G. M. , Prise , V. E. and Chaplin , D. J.Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L‐arginine . Cancer Res. , 57 , 948 – 955 ( 1997. ). [PubMed] [Google Scholar]
  • 22. ) Dark , G. D. , Hill , S. A. , Prise , V. E. , Tozer , G. M. , Pettit , G. R. and Chaplin , D. J.Combretastatin A‐4, an agent that displays potent and selective toxicity toward tumor vasculature . Cancer Res. , 57 , 1829 – 1834 ( 1997. ). [PubMed] [Google Scholar]
  • 23. ) Tozer , G. M. , Prise , V. E. , Wilson , J. , Locke , R. J. , Vojnovic , B. , Stratford , M. R. L. , Dennis , M. F. and Chaplin , D. J.Combretastatin A‐4 phosphate as a tumor vascular‐targeting agent: early effects in tumors and normal tissues . Cancer Res. , 59 , 1626 – 1634 ( 1999. ). [PubMed] [Google Scholar]
  • 24. ) Hori , K. , Saito , S. , Nihei , Y. , Suzuki , M. and Sato , Y.Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A‐4 derivative, AC7700 . Jpn. J. Cancer Res. , 90 , 1026 – 1038 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. ) Hori , K. , Suzuki , M. , Tanda , S. and Saito , S.In vivo analysis of tumor vascularization in the rat . Jpn. J. Cancer Res. , 81 , 279 – 288 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Hori , K. , Suzuki , M. , Tanda , S. , Saito , S. , Shinozaki , M. and Zhang , Q.‐H.Fluctuations in tumor blood flow under normotension and the effect of angiotensin II‐induced hypertension . Jpn. J. Cancer Res. , 82 , 1309 – 1316 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Hori , K. , Zhang , Q.‐H. , Li , H.‐C. , Saito , S. and Sato , Y.Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow . Int. J. Cancer , 65 , 360 – 364 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Aukland , K. , Bower , B. F. and Berliner , R. W.Measurement of local blood flow with hydrogen gas . Circ. Res. , 14 , 164 – 187 ( 1964. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Hori , K. , Zhang , Q.‐H. , Saito , S. , Tanda , S. , Li , H.‐C. and Suzuki , M.Microvascular mechanisms of change in tumor blood flow due to angiotensin II, epinephrine, and methoxamine: a functional morphometric study . Cancer Res. , 53 , 5528 – 5534 ( 1993. ). [PubMed] [Google Scholar]
  • 30. ) Sitzmann , J. V. , Wu , Y. and Cameron , J. L.Altered angiotensin‐II receptors in human hepatocellular and hepatic metastatic colon cancers . Ann. Surg. , 219 , 500 – 507 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. ) Marsigliante , S. , Resta , L. , Muscella , A. , Vinson , G. P. , Marzullo , A. and Storelli , C.AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma . Cancer Lett. , 110 , 19 – 27 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Wu , Y. , Cahill , P. A. and Sitzmann , J. V.Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer . Ann. Surg. , 223 , 225 – 231 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. ) Opocher , G. , Rocco , S. , Cimolato , M. , Vianello , B. , Arnaldi , G. and Mantero , F.Angiotensin II receptors in cortical and medullary adrenal tumors . J. Clin. Endocrinol. Metab. , 82 , 865 – 869 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Kohzuki , M. , Tanda , S. , Hori , K. , Yoshida , K. , Kamimoto , M. , Wu , X. M. and Sato , T.Endothelin receptors and angiotensin II receptors in tumor tissue . J. Cardiovasc. Pharmacol. , 31 ( Suppl. 1 ), S531 – 533 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Matsumura , Y. and Maeda , H.A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs . Cancer Res. , 46 , 6387 – 6392 ( 1986. ). [PubMed] [Google Scholar]
  • 36. ) Maeda , H.SMANCS and polymer‐conjugated macromolecular drugs: advantages in cancer chemotherapy . Adv. Drug Delivery Rev. , 6 , 181 – 202 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Maeda , H. and Miyamoto , Y.SMANCS approach—oily formulations of protein drugs for arterial injection and oral administration . In“Drug Absorption Enhancement Concepts, Possibilities, Limitations and Trends ,” ed. de Boer A. G. , pp. 221 – 247 ( 1994. ). Harwood Academic Publ. , Switzerland . [Google Scholar]
  • 38. ) Stratford , I. J. , Adams , G. E. , Godden , J. , Nolan , J. , Howells , N. and Timpson , N.Potentiation of the antitumour effect of melphalan by the vasoactive agent, hydralazine . Br. J. Cancer , 58 , 122 – 127 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. ) Quinn , P. K. , Bibby , M. C. , Cox , J. A. and Crawford , S. M.The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours . Br. J. Cancer , 66 , 323 – 330 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. ) Parkins , C. S. , Denekamp , J. and Chaplin , D. J.Enhancement of mitomycin‐C cytotoxicity by combination with flavone acetic acid in a murine tumour . Anticancer Res. , 13 , 1437 – 1442 ( 1993. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES